COR-817

N/A

Report date: 2023/10/25 17:10:41
NME

Base Information

Drug NameCOR-817
Drug Alias NameCOR-817COR817
ClassificationSmall molecules
Mechanisms of ActionSARS-CoV-2-3C-like-proteinase inhibitors
TargetsSARS-CoV-2-3C-like-proteinase
Therapy Area/IndicationsCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuince Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesQuince Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A